Wein Matthew 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Wein Matthew（CIK 2009713）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-09-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-10 | Metagenomi Therapeutics, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 卖出 | 358 | $415 |
| 2026-06-10 | Metagenomi Therapeutics, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 卖出 | 558 | $725 |
| 2026-04-03 | Metagenomi Therapeutics, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 买入 | 11,000 | $0 |
| 2026-03-09 | Metagenomi Therapeutics, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 卖出 | 482 | $771 |
| 2025-12-08 | Metagenomi, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 卖出 | 199 | $352 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 卖出 | 199 | $360 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | Title: General Counsel, Compliance Officer and Corporate Secretary | 买入 | 96,000 | $153,600 |
| 2025-06-09 | Metagenomi, Inc. (MGX) | Title: Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary | 卖出 | 199 | $348 |
来源：SEC Form 4 申报文件 · 截至 2026-09-10